» Articles » PMID: 36863507

Hepatoid Adenocarcinoma-Clinicopathological Features and Molecular Characteristics

Overview
Journal Cancer Lett
Specialty Oncology
Date 2023 Mar 2
PMID 36863507
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatoid adenocarcinoma (HAC) is a rare, malignant, extrahepatic tumor with histologic features similar to those of hepatocellular carcinoma. HAC is most often associated with elevated alpha-fetoprotein (AFP). HAC can occur in multiple organs, including the stomach, esophagus, colon, pancreas, lungs, and ovaries. HAC differs greatly from typical adenocarcinoma in terms of its biological aggression, poor prognosis, and clinicopathological characteristics. However, the mechanisms underlying its development and invasive metastasis remain unclear. The purpose of this review was to summarize the clinicopathological features, molecular traits, and molecular mechanisms driving the malignant phenotype of HAC, in order to support the clinical diagnosis and treatment of HAC.

Citing Articles

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review.

Lu G, Tu J, Tu J, Jiang R Front Immunol. 2025; 16:1513604.

PMID: 39931054 PMC: 11808132. DOI: 10.3389/fimmu.2025.1513604.


Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram.

Gu X, Rong J, Zhu L, Dai Z, Ren S, Chen J J Gastrointest Oncol. 2024; 15(5):2041-2052.

PMID: 39554578 PMC: 11565099. DOI: 10.21037/jgo-24-210.


Volume of hepatoid component and intratumor M2 macrophages predict prognosis in patients with hepatoid adenocarcinoma of the stomach.

Taniguchi Y, Kiyozawa D, Kohashi K, Kawatoko S, Yamamoto T, Torisu T Gastric Cancer. 2024; 28(1):41-50.

PMID: 39488822 PMC: 11706836. DOI: 10.1007/s10120-024-01562-x.


A case study of unexplained multiple hepatoid adenocarcinoma of the bone.

Xie Q, Wang L, Cheng J, Chen W, Cai P, Zhang H Quant Imaging Med Surg. 2024; 14(9):7018-7023.

PMID: 39281113 PMC: 11400692. DOI: 10.21037/qims-24-321.


Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis.

Deng H, Wang L, Li Z, Zhan T, Huang L BMC Cancer. 2024; 24(1):948.

PMID: 39095810 PMC: 11297620. DOI: 10.1186/s12885-024-12682-z.